Synthetic biology pioneer Synthorx recruits Cleave’s Laura Shawver for top position – Endpoints News
Endpoints News |
Synthetic biology pioneer Synthorx recruits Cleave’s Laura Shawver for top position
Endpoints News Prominent biotech executive Laura Shawver is taking the helm at Synthorx, a little-known startup blazing the trail for synthetic biology — a field that promises to shake up drug development. Laura Shawver. In Shawver, Synthorx is getting an … |
Science Daily |
Drug-delivering nanoparticles seek and destroy elusive cancer stem cells
Science Daily Cancer stem cells represent a tiny fraction of cells in a tumor, but it only takes one or two to seed a new tumor, Pan said. The challenge for physicians and researchers is not only finding these cells, but treating them. Pan’s group created … Nanoparticles home in on cancer stem cells in promising new therapyNew Atlas |
New Scientist |
Fake embryonic stem cells tested in people with Parkinson’s
New Scientist For the first time, a new type of stem cell, derived from “virgin births”, has been tested in people. The cells have been injected into the brains of people with Parkinson’s disease, and will soon be tried out as a way of fixing physical brain injuries … |